首页 > 产品中心 > 抗体 > Invivo 体内抗体

InVivoMAb Anti-Human IL17F (Iv0028) (ARO-A13351)

价格:
规格:
数量:
  • 概述

  • 图片

  • 参考文献

概述
货号ARO-A13351
品牌ProteoGenix
描述
InVivoMAb Anti-Human IL17F (Iv0028) [Iv0028] (ARO-A13351) is a mouse monoclonal antibody detecting IL17F, Interleukin-17F, IL-17F, Cytokine ML-1 in ELISA, Neutralization. Suitable for Human.
Highlights
  • Protein A/G purified from cell culture supernatant. — Ensuring high specificity and minimal background.
  • Multi-Application — Validated across multiple applications.
种属反应性Human
应用ELISA, Neutralization
宿主Mouse
同种型VHH-mFc
克隆号Iv0028
克隆类型Monoclonal
靶标IL17F, Interleukin-17F, IL-17F, Cytokine ML-1
内毒素水平Please contact with the lab for this information.
纯度>95% as determined by SDS-PAGE.
相关产品 pH 7.4 Dilution Buffer
纯化方式Protein A/G purified from cell culture supernatant.
Accession号Q96PD4
状态Liquid
保存溶液 0.01M PBS, pH 7.4.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

稳定性和存储Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
背景

Interleukin-17F (IL17F) is a ~18 kDa protein. Effector cytokine of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity. IL17A-IL17F signals via IL17RA-IL17RC heterodimeric receptor complex, triggering homotypic interaction of IL17RA and IL17RC chains with TRAF3IP2 adapter through SEFIR domains. This leads to downstream TRAF6-mediated activation of NF-kappa-B and MAPkinase pathways ultimately resulting in transcriptional activation of cytokines, chemokines, antimicrobial peptides and matrix metalloproteinases, with potential strong immune inflammation. IL17A-IL17F is primarily involved in host defense against extracellular bacteria and fungi by inducing neutrophilic inflammation. As signature effector cytokine of T-helper 17 cells (Th17), primarily induces neutrophil activation and recruitment at infection and inflammatory sites.

1. Puel, A. et al. (2011) Science (New York, N.Y.) 332, 65-8. PMID: 21350122
2. Hymowitz, SG. et al. (2001) The EMBO journal 20, 5332-41. PMID: 11574464
3. Starnes, T. et al. (2001) Journal of immunology (Baltimore, Md. : 1950) 167, 4137-40. PMID: 11591732
4. Kawaguchi, M. et al. (2001) Journal of immunology (Baltimore, Md. : 1950) 167, 4430-5. PMID: 11591768
5. Kuestner, RE. et al. (2007) Journal of immunology (Baltimore, Md. : 1950) 179, 5462-73. PMID: 17911633
6. Wright, JF. et al. (2008) Journal of immunology (Baltimore, Md. : 1950) 181, 2799-805. PMID: 18684971
7. Goepfert, A. et al. (2017) Scientific reports 7, 8906. PMID: 28827714
8. Goepfert, A. et al. (2020) Immunity 52, 499-512.e5. PMID: 32187518
NoteFor research use only. Not suitable for clinical or therapeutic use.
图片
参考文献
公式
质量 (g) = 浓度 (mol/L) × 体积 (L) × 分子量 (g/mol)
填写 质量、浓度、体积中的任意 2 项 + 分子量,自动计算未知值。
质量
=
浓度
×
体积
分子量 *
g/mol
公式
C₁ × V₁ = C₂ × V₂
填写 4 项中的任意 3 项,自动计算未知值。
母液
C₁ (起始浓度)
×
V₁ (起始体积)
=
工作液
C₂ (终浓度)
×
V₂ (终体积)

相关产品推荐